To further uncover the underlying mechanisms by which COPD inflammation was reduced, we focused on TLR-4/NF-κB pathway-related molecules (because no difference was found in the efficacy between the SA and model groups, the SA group was not used for the mechanism studies). The gene discussed is TLR4; the disease is chronic obstructive pulmonary disease.